Ozempic Death Lawsuit Claims [November 2024 Update] | Wrongful Death Ozempic Claims

Recent Reports Link Ozempic to Deaths

Reports indicate that Ozempic and similar weight-loss drugs like Wegovy and Mounjaro are associated with countless deaths across the United States.

According to the United States Food and Drug Administration (FDA) FAERS database, zempic and other popular GLP-1 weight loss drugs, including Wegovy and Mounjaro, have been associated with a total of 162 deaths in the United States over the past six years.

These reports include serious side effects such as gastrointestinal complications, pancreatitis, and severe vomiting episodes.

While these adverse events are significant, FAERS data alone doesn’t establish a direct causal link between the medications and the reported fatalities.

Instead, it highlights potential safety concerns that may warrant further investigation into the drugs’ risks and benefits, especially given their widespread use and popularity for weight loss.

Among the adverse events reported, 94 deaths were linked to semaglutide (the active ingredient in Ozempic and Wegovy), while the remaining 68 were associated with tirzepatide, used in Mounjaro.

These findings have sparked further discussions within the medical community regarding the need for comprehensive studies to better understand the long-term effects of these medications on patients’ health, particularly those using them off-label for weight management.

Potential Health Problems Linked to Ozempic, Wegovy, and Other Weight Loss Drugs

Recent studies and reports highlight that Ozempic, Wegovy, and other GLP-1 receptor agonist drugs are associated with serious health risks, including stomach paralysis, also known as gastroparesis, as well as other gastrointestinal issues.

Gastroparesis limits the stomach’s ability to empty properly, causing symptoms like intense vomiting, nausea, and abdominal pain.

One study analyzed the records of millions of U.S. patients and found that those using GLP-1 agonists for weight loss faced an elevated risk of not only gastroparesis but also bowel obstructions and pancreatitis.

Specifically, this study revealed that patients taking these drugs had three times the risk of stomach paralysis and a nine-fold increase in pancreatitis compared to those using other weight loss medications.

The implications of these findings are significant, especially considering the rapid rise in the popularity of GLP-1 medications for weight loss.

Given the severe nature of these potential adverse events, some researchers are calling for updated warning labels to ensure patients are aware of the risks.

As the number of individuals using these drugs continues to grow, understanding the full spectrum of potential side effects has become crucial​.

Potential Health Problems Linked to GLP-1 Agonists like Ozempic and Wegovy:

• Gastroparesis (Stomach Paralysis): Leads to delayed stomach emptying, causing persistent nausea and vomiting.
• Bowel Obstruction: Blocks food from passing through the intestines, resulting in pain and bloating.
• Pancreatitis: Inflammation of the pancreas, often linked to severe abdominal pain.
• Biliary Disease: Conditions affecting the gallbladder, including inflammation and blockages.

Does Ozempic’s Warning Label Consider These Serious Side Effects?

The FDA has updated the Ozempic label to address concerns regarding the risk of bowel obstruction, particularly ileus, a condition where the intestine becomes partially or fully blocked.

This change, implemented in 2023, aligns Ozempic’s label with those of related GLP-1 drugs like Wegovy and Mounjaro, which had previously listed this risk.

Ileus is noted as potentially life-threatening, and the FDA Adverse Event Reporting System (FAERS) has recorded 33 cases, including two fatalities, linked to GLP-1 agonists.

Although these adverse events are reported voluntarily and don’t prove causation, the growing reports have prompted additional label warnings to enhance patient safety.

Novo Nordisk has reportedly expressed commitment to working closely with the FDA, stating that gastrointestinal side effects are known risks of GLP-1 medications and are typically mild and temporary for most patients.

However, this label update aims to better inform patients of potential risks associated with these popular drugs, especially when used off-label for weight loss.

Ozempic Lawsuit Overview

Ozempic manufacturer Novo Nordisk, as well as the manufacturer of other weight loss drugs Eli Lilly, are facing lawsuits from countless individuals who have developed severe side effects.

Ozempic Lawsuits allege that drug manufacturers Novo Nordisk and Eli Lilly failed to adequately warn consumers and healthcare providers about the risks of conditions such as gastroparesis (stomach paralysis), bowel obstruction, and related digestive complications.

Ozempic Lawsuits argue that the drugmakers downplayed or omitted critical risk information on the labels, leading to unexpected and sometimes life-threatening outcomes for patients.

In response, the U.S. Judicial Panel on Multidistrict Litigation centralized these cases into the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation (MDL 3094) in Pennsylvania federal court to manage the rising number of claims more efficiently.

The Ozempic MDL is moving forward under the supervision of Judge Karen Marston, following the unexpected passing of Judge Gene Pratter, who initially presided over the case when the Ozempic Lawsuits began.

The Ozempic mass tort litigation has gained momentum as additional plaintiffs have reported additional health conditions, including NAION (a vision-related condition) and fatal consequences.

If evidence relating to the medical and scientific issues is admitted into court, it could broaden the scope of injuries considered in the Ozempic MDL.

If you were prescribed Ozempic or other weight loss drugs under the GLP-1 class and subsequently suffered health problems, you may be eligible to file an Ozempic Lawsuit and seek compensation.

Reach out to an Ozempic Lawyer from our law firm for a free consultation.

Use the chatbot on this page to find out if you qualify for the Ozempic Lawsuit instantly.

Is There an Ozempic Class Action Lawsuit?

No, there is not an Ozempic Class Action Lawsuit.

As mentioned, Ozempic Lawsuits related to severe health issues filed by many patients are consolidated into multidistrict litigation (MDL).

This means each plaintiff’s case remains individual rather than combined into a single lawsuit.

In a class action, a single case is filed on behalf of all affected individuals, who share any settlement or verdict equally regardless of individual circumstances.

Conversely, an MDL allows each plaintiff to pursue their case independently, meaning compensation is tailored to their specific injuries and losses while benefiting from shared discovery and streamlined pretrial proceedings.

This structure in MDL cases is often advantageous in mass tort cases where injuries vary significantly among plaintiffs.

Do You Qualify for the Ozempic Lawsuit?

Makers of the weight loss medication Ozempic have failed to properly warn patients about the serious side effects and risks related to these drugs.

As a result, countless individuals have suffered severe health complications, including stomach paralysis, bowel obstruction, and gastroparesis, which can lead to long-term damage and ongoing medical needs.

Ozempic Lawsuits claim that these side effects have dramatically impacted users’ lives, causing chronic pain, financial burdens due to medical expenses, and emotional distress.

The Ozempic Lawsuits aim to hold the manufacturers accountable for neglecting their duty to inform the public and healthcare providers of the full range of risks associated with these medications.

Plaintiffs are seeking compensation not only for current medical bills but also for the future expenses and lifestyle changes necessitated by these life-altering injuries.

If you’ve taken Ozempic or other weight loss drugs and suffered injuries, you may be eligible to file a lawsuit.

If your family member or loved one tragically passed away due to Ozempic-related health problems, you may be eligible to file an Ozempic Death Lawsuit and seek compensation for funeral expenses, emotional pain and suffering, and other relevant damages.

Reach out to our law firm today for a free consultation, or use the chat feature on this page for an instant case evaluation.

Gathering Evidence for Ozempic Wrongful Death Lawsuits

Losing a loved one to severe complications from medications like Ozempic is devastating, and gathering evidence is a critical part of the wrongful death lawsuit process to seek justice.

Family members who have experienced such a loss may face emotional and financial burdens, making it essential to document the journey and effects in as much detail as possible.

Evidence can be complex to gather and may require both personal records and insights from medical professionals, showing the profound impact of the loss.

By compiling thorough evidence, families strengthen their case, showing how the medication’s risks were hidden or inadequately communicated.

Working closely with an attorney can help in organizing these materials to ensure all aspects of the claim are covered.

Evidence to collect may include:

• Medical Records: Comprehensive records of the deceased’s medical history, treatments, and prescribed use of Ozempic or similar drugs.
• Prescription Documentation: Proof of Ozempic prescriptions, including dates and dosages, can establish a timeline and correlation with health issues.
• Doctor and Specialist Reports: Statements and notes from healthcare providers explaining the link between Ozempic use and health complications leading to death.
• Death Certificate: Documentation that lists the cause of death, particularly if linked to known Ozempic side effects.
• Autopsy and Toxicology Reports: Detailed findings that may clarify the role of Ozempic in the patient’s passing.
• Communication with Manufacturers: Any records of reported side effects or complaints filed by the patient or family, as well as responses from the drug manufacturers.
• Witness Statements: Statements from family members or friends about the impact on the deceased’s quality of life after starting Ozempic, illustrating the changes experienced firsthand.

Assessing Damages in Ozempic Death Claims

In a legal context, damages refer to the financial compensation awarded to plaintiffs for losses and suffering caused by a defendant’s actions, including wrongful death cases.

For families impacted by an Ozempic-related death, assessing damages helps quantify the financial and emotional toll of losing a loved one due to severe side effects.

This process seeks to acknowledge both tangible losses, such as medical bills and funeral expenses, and intangible losses, such as emotional pain and loss of companionship.

Evaluating damages requires thorough documentation to build a comprehensive picture of the family’s hardships and ongoing needs.

Damages to consider in Ozempic death claims may include:

• Medical Expenses: Costs for all treatments, hospital stays, and emergency care related to Ozempic side effects leading up to the patient’s death.
• Funeral and Burial Costs: Expenses associated with honoring and laying the deceased to rest, which can create additional financial burdens for grieving families.
• Loss of Financial Support: Income the deceased would have contributed to the household, particularly if they were a primary earner, can be critical in wrongful death claims.
• Pain and Suffering: Compensation for the emotional distress and psychological toll endured by both the deceased and their loved ones due to the prolonged or sudden nature of the illness.
• Loss of Companionship: Damages for the loss of relationship, support, and love the deceased provided to their family members.
• Loss of Parental Guidance: For children of the deceased, compensation may account for the guidance, education, and support a parent would have provided throughout their lives.
• Punitive Damages: If applicable, punitive damages may be awarded to penalize the drug manufacturer for negligence or willful misconduct, emphasizing the importance of transparent and safe practices in the pharmaceutical industry.

TorHoerman Law: Your Ozempic Lawyer

Our plaintiff lawyers are currently investigating Ozempic cases from family members and loved ones of people who have tragically passed away due to complications from taking Ozempic or other medications used for chronic weight management.

We understand that losing a loved one due to severe side effects from medications like Ozempic can be an overwhelming and devastating experience.

Our team of dedicated Ozempic attorneys is here to support families in their pursuit of justice and fair compensation, ensuring that their case is handled with the empathy and diligence it deserves.

At TorHoerman Law, we are committed to thoroughly investigating each claim, gathering essential evidence, and working closely with families to address both immediate and long-term needs in wrongful death lawsuits.

If you have lost a loved one due to complications linked to Ozempic, please contact our experienced team for a free consultation.

We are here to guide you through this difficult time and provide the legal support you deserve.

Reach out today to discuss your case and explore your options for justice.